Literature DB >> 26084415

Global public awareness of venous thromboembolism.

A M Wendelboe1, M McCumber1, E M Hylek2, H Buller3, J I Weitz4, G Raskob1.   

Abstract

BACKGROUND: Data on public awareness about thrombosis in general and venous thromboembolism (VTE) in particular are limited. We aimed to measure the global awareness of thrombosis to address this gap.
METHODS: With Ipsos-Reid, from 22 July to 5 August 2014, we surveyed 800 respondents in their native language from each of Argentina, Australia, Canada, Germany, Japan, Thailand, the Netherlands, the United Kingdom and the United States to measure general awareness about thrombosis, including deep vein thrombosis (DVT) and pulmonary embolism (PE). In each country, respondents were distributed among three age groups: 18-39 years, 40-64 years, and over 65 years of age. Proportions and 95% confidence intervals (CIs) were calculated.
RESULTS: Overall, the proportion of respondents that were aware of thrombosis, DVT and PE (68%, 44% and 54%, respectively) was lower than the proportion that was aware of other thrombotic disorders, such as heart attack and stroke (88% and 85%, respectively), and health conditions such as hypertension, breast cancer, prostate cancer and AIDS (90%, 85%, 82% and 87%, respectively). Although there was variation across countries, lower awareness was associated with younger age and being male. Only 45% (95% CI, 43.9-46.5) of respondents were aware that blood clots were preventable, and awareness of cancer, hospitalization and surgery as risk factors was low (16%, 25%, and 36%, respectively).
CONCLUSIONS: On a global level, public awareness about thrombosis overall, and VTE in particular, is low. Campaigns to increase public awareness about VTE are needed to reduce the burden from this largely preventable thrombotic disorder.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  awareness; prevention; public health; risk factors; thrombosis; venous thromboembolism

Mesh:

Year:  2015        PMID: 26084415     DOI: 10.1111/jth.13031

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  30 in total

1.  Chemical Modulators of Fibrinogen Production and Their Impact on Venous Thrombosis.

Authors:  Rui Vilar; Samuel W Lukowski; Marco Garieri; Corinne Di Sanza; Marguerite Neerman-Arbez; Richard J Fish
Journal:  Thromb Haemost       Date:  2020-12-10       Impact factor: 5.249

2.  Low awareness of venous thromboembolism among the general population: a call for increased public enlightenment programs.

Authors:  Helen Okoye; Theresa Nwagha; Eyiuche Ezigbo; Oji Nnachi; Onochie Obodo; Oluomachi Nnachi; Nneka Amu; Ikechukwu Anigbogu
Journal:  J Prev Med Hyg       Date:  2021-09-15

3.  Forensic autopsy-confirmed thrombosis-related deaths: the danger in the bones.

Authors:  Walter J Janse van Rensburg; Leriska Haupt
Journal:  J Thromb Thrombolysis       Date:  2022-08-13       Impact factor: 5.221

Review 4.  Epidemiology and prevention of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai
Journal:  Nat Rev Cardiol       Date:  2022-10-18       Impact factor: 49.421

5.  Improving Awareness and Outcomes Related to Venous Thromboembolism.

Authors:  Mary Cushman; Mark A Creager
Journal:  JAMA       Date:  2015-11-10       Impact factor: 56.272

6.  Clinical profile and management of patients with acute pulmonary thromboembolism - a single centre, large observational study from India.

Authors:  Thoddi Ramamurthy Muralidharan; Sankaran Ramesh; Balakrishnan Vinod Kumar; Aditya V Ruia; Mohan Kumar; Akshaya Gopalakrishnan; Gurpreet S Johal; Amit Hooda; Rohit Malhotra; Reza Masoomi; Mahalakshmi Ramadoss; Vinodhini Subramanian; Maria J Kalsingh; Panchanatham Manokar; Jebaraj Rathinasamy; Shanmugasundram Sadhanandham; Jayanthy V Balasubramaniyan; Preetam Krishnamurthy; Jayanthy S Murthy; Sadagopan Thanikachalam; Nagendra Boopathy Senguttuvan
Journal:  Pulm Circ       Date:  2021-02-16       Impact factor: 3.017

7.  Awareness, knowledge, and attitude toward venous thromboembolism among Aseer Population, Saudi Arabia.

Authors:  Ali Al Bshabshe; Wesam Faried Mousa; Mohammed Sultan Alshehri; Mazen Mohammed Saeed Alshahrani; Omar Mohammed Alamri; Fayez Saeed Alshehri; Mohammed Ali AlFlan; Afnan Sultan Alshehri
Journal:  J Family Med Prim Care       Date:  2021-07-02

8.  Association of MMP-2 gene haplotypes with thoracic aortic dissection in chinese han population.

Authors:  Ou Liu; Jiachen Li; Yi Xin; Yanwen Qin; Haiyang Li; Ming Gong; Yuyong Liu; Xiaolong Wang; Jianrong Li; Hongjia Zhang
Journal:  BMC Cardiovasc Disord       Date:  2016-01-14       Impact factor: 2.298

9.  Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis.

Authors:  Masanobu Takeuchi; Tohru Kobayashi; Leonardo R Brandão; Shinya Ito
Journal:  Syst Rev       Date:  2016-06-23

10.  Patient Preferences for Receiving Education on Venous Thromboembolism Prevention - A Survey of Stakeholder Organizations.

Authors:  Victor O Popoola; Brandyn D Lau; Hasan M Shihab; Norma E Farrow; Dauryne L Shaffer; Deborah B Hobson; Susan V Kulik; Paul D Zaruba; Kenneth M Shermock; Peggy S Kraus; Peter J Pronovost; Michael B Streiff; Elliott R Haut
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.